
Minze Biosciences Private Limited
About Minze Biosciences Private Limited
Data last updated:
Minze Biosciences Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the chemical products segment of the chemicals sector. It was incorporated on 06 February 2013 and has been in existence for over 13 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24233DL2013PTC247982. Its GSTIN is 07AAICM5518L1Z4 (Delhi).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Sudesh Kumar Gautam and Devendra Gautam.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 1/2761 – A Khasra No, Ram Nagar Mandoli Road, New Delhi, Delhi, India – 110032.
As per the financials filed for FY 2025, the company reported a revenue of ₹8.17 Lakh, a decline of 4% compared to the previous year. For the same year it recorded a net loss of ₹9,891 (net margin -1.2%) and EBITDA of -₹6,341 (EBITDA margin -0.8%). Revenue has declined at a compounded annual rate (CAGR) of 9% over three years and 6% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Minze Biosciences Private Limited's registered office is in New Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address1/2761 – A Khasra No, Ram Nagar Mandoli Road, New Delhi, Delhi, India – 110032
- IndustryChemicals, Chemical Products, Medicinal Chemical & Botanical Products, Pharmaceuticals
To see the full contact details of Minze Biosciences Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Minze Biosciences is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Minze Biosciences Private Limited, buy the company report.
Financials of Minze Biosciences Private Limited
FY 2025 filings availableMinze Biosciences Private Limited reported revenue of ₹8.17 Lakh (down 4% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 6% over five years, including a 4% fall in the latest year. EBITDA rose 35% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹6,341 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹9,891 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -0.8% | ||||
| Net Profit Margin | -1.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Minze Biosciences Private Limited, buy the company report.
Board of directors of Minze Biosciences Private Limited
Minze Biosciences has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sudesh Kumar Gautam | Director | 06 Feb 2013 | 13 Years 8 Months | Current |
| Devendra Gautam | Director | 07 Aug 2021 | 5 Years 2 Months | Current |
Auditor
Minze Biosciences Private Limited is audited by Ravi Ankur & Co. for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Ravi Ankur & Co. | FY 2017 | 029208N |
Shareholding
The shareholding of Minze Biosciences Private Limited is on record for FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Foreign institutional investors (FII) | |
| Public | |
| Others |
To see the full shareholding pattern of Minze Biosciences Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Minze Biosciences Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Minze Biosciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Minze Biosciences has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAICM5518L1Z4 | Delhi | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Minze Biosciences Private Limited, buy the company report.
Recent activity
Minze Biosciences Private Limited has 4 board changes on record since 2013: 2 appointments and 2 cessations. The latest: Devendra Gautam was appointed as Director on 07 Aug 2021.
Frequently asked questions
Minze Biosciences is an active private limited company based in New Delhi, Delhi, India. The company works in chemical products, within the chemicals industry. It was incorporated on 06 February 2013 (13+ years old) and is registered under CIN U24233DL2013PTC247982.
Minze Biosciences has 2 current directors:
- Sudesh Kumar Gautam - Director
- Devendra Gautam - Director
The latest financial statements of Minze Biosciences on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Minze Biosciences is 07AAICM5518L1Z4, registered in Delhi.
The CIN (Corporate Identification Number) of Minze Biosciences is U24233DL2013PTC247982. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Minze Biosciences was incorporated on 06 February 2013, making it 13+ years old. It is registered with the Registrar of Companies, Delhi.
Devendra Gautam was appointed as Director on 07 Aug 2021. Tarash Chand Jain ceased to be Director on 07 Aug 2021. Ashish Roy ceased to be Director on 20 Feb 2016. Minze Biosciences has 4 board changes on record in total.
The registered office of Minze Biosciences is at 12761 – A Khasra No, Ram Nagar Mandoli Road, New Delhi, Delhi, India – 110032.
Minze Biosciences operates in the chemicals industry, in the chemical products segment.
The compliance status of Minze Biosciences is compliant as of 17 July 2026. The company is actively filing with the Registrar of Companies.

